They display higher expression of immunosuppressive molecules and more robust inhibition of CD8+ T cells when stimulated by AREG.[374] This suggests that EGFR activation in Tregs plays a significant role in promoting an immunosuppressive tumor microenvironment. The gene discussed is CD8A; the disease is neoplasm.